RecruitingNCT07680946
About this title
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Read the official source — NCT07680946What is this study about?Researchers are studying Ublituximab to find out how it affects psychotic symptoms in people with schizophrenia.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- TG Therapeutics, Inc.
RecruitingNCT05303064
About this title
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Read the official source — NCT05303064Official study titleA Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)
Multiple locations, including DothanBipolarity, SchizophreniaMedication studyAges 10–17
- Countries
- United States, Argentina, Brazil, + 2 others
- Sponsor
- Alkermes, Inc.
RecruitingACTRN12613000103763
Official study titleAn open trial of examining the efficacy and acceptability of an internet-delivered cognitive behaviour therapy (CBT) program for adult dialysis patients with symptoms of anxiety and depression.
In AustraliaAnxiety, DepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Renal Unit, Liverpool Hospital
RecruitingACTRN12615000566538
Official study titleStudying the antidepressant effects of intravenous ketamine in patients with major depressive disorder
In SingaporeDepressionInterventional studyAges 21–65
- Countries
- Singapore
- Sponsor
- National University of Singapore
RecruitingACTRN12609000011280
Official study titleThe effect in healthy volunteers of administration of the selective serotonin reuptake inhibitor escitalopram (10 mg/day for 3 weeks) vs. placebo on drug initiation effects and experimentally-induced anxiety.
Location not clearly listedAnxietyInterventional studyAges 18–65
- Countries
- Sponsor
- University of Western Australia
RecruitingNCT07247968
About this title
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
Read the official source — NCT07247968Official study titleClinical and Mechanistic Study of Subanesthetic-dose Esketamine in Modified Electroconvulsive Therapy for Adolescents With Severe Depression
In ChongqingDepressionMedication studyAges 13–17
- Countries
- China
- Sponsor
- Min Su
RecruitingNCT07639359
About this title
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Read the official source — NCT07639359What is this study about?Researchers are comparing Ketamine (0.5 mg/kg) and placebo to find out how the approaches affect depression symptoms in people with depression.
Multiple locations, including JacksonvilleDepressionMedication studyAges 18–99
- Countries
- United States, Argentina
- Sponsor
- Hospital Italiano de Buenos Aires
RecruitingNCT07492537
About this title
SUBDIMA: Subclinical Depression in Acute Myocardial Infarction (SUBDIMA25)
Read the official source — NCT07492537Official study titleSUBDIMA Study: Subclinical Depression in Myocardial Infarction -Prevalence, Predictors and Prognostic Impact.
In RomaDepressionInterventional studyAges 18+
- Countries
- Italy
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingEUCTR 2021-001817-35
About this title
Treatment of opioid dependency in patients with chronic pain: a comparative study between suboxone and methadone. Behandeling van opiaatafhankelijkheid bij pijn: een vergelijkende studie met suboxone en methadon.
Read the official source — 2021-001817-35Official study titleSuboxone (buprenorphine/naloxone) versus methadone opioid rotation in patients with escalated opioid use and chronic pain: a randomized trial.
Original registry wording; source language not specified.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
In NijmegenAddictionHistorical research record
- Countries
- Netherlands
- Sponsor
- Radboud University Medical Center
RecruitingNCT04459000
About this title
Substance Use Treatment and Access to Resources (STARS) Project
Read the official source — NCT04459000Official study titleSubstance Use Treatment and Access to Resources (STARS) Project
In Oklahoma CityAddictionBehavioural studyUp to age 55
- Countries
- United States
- Sponsor
- University of Oklahoma
RecruitingACTRN12619000724178
Official study titleAssociation between subthreshold depression and self-care behaviours in adults with type 2 diabetes: a cross-sectional survey
In NepalDepressionObservational studyAges 18+
- Countries
- Nepal
- Sponsor
- La Trobe University
RecruitingNCT04366531
About this title
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
Read the official source — NCT04366531Official study titleDevelopment of a Psycho-social Transition Program and Transition Assessment Tools for Veterans With Mental Illness and/or Substance Use Disorders Leaving Prison
In DallasAddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)